These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17691760)

  • 1. Isolation, characterization, and biological evaluation of syn and anti diastereomers of [(99m)Tc]technetium depreotide: a somatostatin receptor binding tumor imaging agent.
    Cyr JE; Pearson DA; Nelson CA; Lyons BA; Zheng Y; Bartis J; He J; Cantorias MV; Howell RC; Francesconi LC
    J Med Chem; 2007 Sep; 50(18):4295-303. PubMed ID: 17691760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterization, conformational analysis of a cyclic conjugated octreotate peptide and biological evaluation of (99m)Tc-HYNIC-His(3)-Octreotate as novel tracer for the imaging of somatostatin receptor-positive tumors.
    Behera A; Banerjee I; De K; Munda RN; Chattopadhayay S; Samanta A; Sarkar B; Ganguly S; Misra M
    Amino Acids; 2013 Mar; 44(3):933-46. PubMed ID: 23090293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental study of 99mTc-depreotide preparation and its affinity with A549 cell.
    Xia W; Zhang X; Yu F; Wang P; Cai H; Hou R; Wang G; Yuan X; Lv Z
    Front Biosci (Landmark Ed); 2011 Jun; 16(7):2527-39. PubMed ID: 21622193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MO tripeptide diastereomers (M=99/99mTc, Re): models to identify the structure of 99mTc peptide targeted radiopharmaceuticals.
    Cantorias MV; Howell RC; Todaro L; Cyr JE; Berndorff D; Rogers RD; Francesconi LC
    Inorg Chem; 2007 Sep; 46(18):7326-40. PubMed ID: 17691766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (99m)Tc-labeled dimeric octreotide peptide: a radiotracer with high tumor uptake for single-photon emission computed tomography imaging of somatostatin receptor subtype 2-positive tumors.
    Dong C; Zhao H; Yang S; Shi J; Huang J; Cui L; Zhong L; Jin X; Li F; Liu Z; Jia B; Wang F
    Mol Pharm; 2013 Aug; 10(8):2925-33. PubMed ID: 23768172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestrogen-mediated regulation of somatostatin receptor expression in human breast cancer cell lines assessed with 99mTc-depreotide.
    Van Den Bossche B; D'haeninck E; De Vos F; Dierckx RA; Van Belle S; Bracke M; Van de Wiele C
    Eur J Nucl Med Mol Imaging; 2004 Jul; 31(7):1022-30. PubMed ID: 15029461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in biodistribution between 99mTc-depreotide, 111In-DTPA-octreotide, and 177Lu-DOTA-Tyr3-octreotate in a small cell lung cancer animal model.
    Schmitt A; Bernhardt P; Nilsson O; Ahlman H; Kölby L; Forssell-Aronsson E
    Cancer Biother Radiopharm; 2005 Apr; 20(2):231-6. PubMed ID: 15869461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical evaluation of [99mTc/EDDA/tricine/HYNIC0, 1-Nal3, Thr8]-octreotide as a new analogue in the detection of somatostatin-receptor-positive tumors.
    Gandomkar M; Najafi R; Shafiei M; Mazidi M; Ebrahimi SE
    Nucl Med Biol; 2007 Aug; 34(6):651-7. PubMed ID: 17707805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of [99mTc/EDDA/HYNIC0]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization?
    Storch D; Béhé M; Walter MA; Chen J; Powell P; Mikolajczak R; Mäcke HR
    J Nucl Med; 2005 Sep; 46(9):1561-9. PubMed ID: 16157541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-clinical evaluation of a new indirectly labeled ⁹⁹mTc-6-hydrazinopyridine-3-carboxylic acid (HYNIC)-depreotide with HYNIC as bifunctional chelator.
    Yu F; Lü ML; Zhang XP; Fu D; Hou M; Cai HD; Li D; Wang J; Yuan XY; Lü ZW; Dong F
    Chin Med J (Engl); 2012 Jul; 125(14):2538-42. PubMed ID: 22882936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and biological evaluation of [(99m)Tc/EDDA/Tricine/HYNIC(0), BzThi(3)]-octreotide for somatostatin receptor-positive tumor imaging.
    Erfani M; Shafiei M; Mazidi M; Goudarzi M
    Cancer Biother Radiopharm; 2013 Apr; 28(3):240-7. PubMed ID: 23464855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin receptor-binding peptides suitable for tumor radiotherapy with Re-188 or Re-186. Chemistry and initial biological studies.
    Cyr JE; Pearson DA; Wilson DM; Nelson CA; Guaraldi M; Azure MT; Lister-James J; Dinkelborg LM; Dean RT
    J Med Chem; 2007 Mar; 50(6):1354-64. PubMed ID: 17315859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging somatostatin receptor activity in patients with active thyroid eye disease using Tc-99m depreotide.
    Doumas AS; Krassas GE; Kaltsas T; Pontikides N
    Clin Nucl Med; 2003 May; 28(5):439-40. PubMed ID: 12702954
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitative assessment of 99mTc-depreotide uptake in patients with non-small-cell lung cancer: immunohistochemical correlations.
    Herlin G; Kölbeck KG; Menzel PL; Svensson L; Aspelin P; Capitanio A; Axelsson R
    Acta Radiol; 2009 Oct; 50(8):902-8. PubMed ID: 19707908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and staging of children's lymphoma using the technetium-labelled somatostatin analogue, 99mTc-depreotide.
    Cholewinski W; Kowalczyk JR; Stefaniak B; Stefaniak J; Poniatowicz-Frasunek E; Tarkowska A
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31(6):820-4. PubMed ID: 14762697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin receptor imaging of non-small cell lung cancer with 99mTc depreotide.
    Menda Y; Kahn D
    Semin Nucl Med; 2002 Apr; 32(2):92-6. PubMed ID: 11965604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [(99m)Tc]Demotate 2 in the detection of sst(2)-positive tumours: a preclinical comparison with [(111)In]DOTA-tate.
    Maina T; Nock BA; Cordopatis P; Bernard BF; Breeman WA; van Gameren A; van den Berg R; Reubi JC; Krenning EP; de Jong M
    Eur J Nucl Med Mol Imaging; 2006 Jul; 33(7):831-40. PubMed ID: 16568203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Tc-99m depreotide scintigraphy in the evaluation of solitary pulmonary nodules.
    Grewal RK; Dadparvar S; Yu JQ; Babaria CJ; Cavanaugh T; Sherman M; Jacobstein J
    Cancer J; 2002; 8(5):400-4. PubMed ID: 12416898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiolabeled new somatostatin analogs conjugated to DOMA chelator used as targeted tumor imaging agent: synthesis and radiobiological evaluation.
    De K; Banerjee I; Misra M
    Amino Acids; 2015 Jun; 47(6):1135-53. PubMed ID: 25743164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [(99m)Tc]Demomedin C, a radioligand based on human gastrin releasing peptide(18-27): synthesis and preclinical evaluation in gastrin releasing peptide receptor-expressing models.
    Nock BA; Cescato R; Ketani E; Waser B; Reubi JC; Maina T
    J Med Chem; 2012 Oct; 55(19):8364-74. PubMed ID: 22966957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.